LRRN3 and Parkinson disease: To validate LRRN3 and TUBB2A as potential blood biomarkers for PD, we measured mRNA expression levels of these two genes in the blood of an independent cohort comprising 49 sporadic PD patients and 50 control subjects (Table 3).